US2013210740A1PendingUtilityA1

Neo-tryptophan

59
Assignee: RICHELSON ELLIOTTPriority: Apr 10, 1998Filed: Aug 21, 2012Published: Aug 15, 2013
Est. expiryApr 10, 2018(expired)· nominal 20-yr term from priority
Inventors:Elliott RichelsonBernadette Marie CusackYuan-Ping PangDaniel J. MccormickAbdul FauqBeth Marie TylerMona Boules
A61P 29/00C07K 7/18C07K 7/083C07K 7/14A61K 38/00C07K 14/702C07D 209/08A61P 25/04C07K 14/70
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods of inducing antinociception in a human are described. The method includes the step of administering an effective dose of a polypeptide comprising L-neo-tryptophan to the human extracranially. The polypeptide containing L-neo-tryptophan could be, but is not limited to, NT64L, NT65L, NT66L, NT67L, NT69L, NT69L′, NT71, NT72, NT73, NT74, NT75, NT76, or NT77.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method of inducing antinociception in a human, said method comprising administering an effective dose of a polypeptide comprising L-neo-tryptophan to the human extracranially. 
     
     
         2 . The method of  claim 1 , wherein the polypeptide is selected from the group consisting of NT64L, NT65L, NT66L, NT67L, NT69L, NT69L, NT71, NT72, NT73, NT74, NT75, NT76, and NT77. 
     
     
         3 . A method of inducing antinociception in a human, said method comprising administering an effective dose of one or more of NT64L, NT65L, NT66L, NT67L, NT69L, NT69L′, NT71, NT72, NT73, NT74, NT75, NT76, and NT77.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.